Stock Price
9.24
Daily Change
0.05 0.49%
Monthly
-41.59%
Yearly
-49.81%
Q2 Forecast
8.91

Adma Biologics reported $2.2B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Novavax USD 1.09B 316M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025